Terms: = Pancreatic cancer AND EIF3E, eIF3-p46, 3646, ENSG00000104408, EIF3S6, eIF3e, EIF3-P48, INT6 AND Treatment
3 results:
1. Evaluation of Adjuvant Chemotherapy in Patients With Resected pancreatic cancer After Neoadjuvant FOLFIRINOX treatment.
van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG;
JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170
[TBL] [Abstract] [Full Text] [Related]
2. Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience.
Klaassen R; Steins A; Gurney-Champion OJ; Bijlsma MF; van Tienhoven G; Engelbrecht MRW; van Eijck CHJ; Suker M; Wilmink JW; Besselink MG; Busch OR; de Boer OJ; van de Vijver MJ; Hooijer GKJ; Verheij J; Stoker J; Nederveen AJ; van Laarhoven HWM
Mol Oncol; 2020 Sep; 14(9):2176-2189. PubMed ID: 32285559
[TBL] [Abstract] [Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.
Ranieri G; Patruno R; Ruggieri E; Montemurro S; Valerio P; Ribatti D
Curr Med Chem; 2006; 13(16):1845-57. PubMed ID: 16842197
[TBL] [Abstract] [Full Text] [Related]
